Financhill
Back

Prothena Corp. Plc Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Sell
16

PRTA
Prothena Corp. Plc

Last Price:
$9.66
Seasonality Move:
5.27%
Sell
41

MNPR
Monopar Therapeutics, Inc.

Last Price:
$70.95
Seasonality Move:
25.93%
Sell
16
Prothena Corp. Plc (PRTA) is a Sell

Is Prothena Corp. Plc a Buy, Sell or Hold?

  • The current Prothena Corp. Plc [PRTA] share price is $9.68. The Score for PRTA is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • PRTA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
41
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $70.92. The Score for MNPR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRTA Stock Price Chart

What is Prothena Corp. Plc's stock price today?

  • The Prothena Corp. Plc share price today is $9.68
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRTA is experiencing buying pressure, which is a positive indicator for future bullish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $70.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

PRTA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.1 Buy
Relative Strength Index (14 RSI): 44.03 Sell
Chaikin Money Flow: 494209 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.74 - 10.76) Sell
Bollinger Bands (100): (8.34 - 10.52) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.54 Sell
Relative Strength Index (14 RSI): 41.3 Sell
Chaikin Money Flow: 7856 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (71.72 - 85.64) Sell
Bollinger Bands (100): (46.03 - 89.35) Buy

PRTA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.76 Sell
20-day SMA: 10.26 Sell
50-day SMA: 10.28 Sell
200-day SMA: 8.82 Buy
8-day EMA: 5.99 Buy
20-day EMA: 3.11 Buy
50-day EMA: 1.39 Buy
200-day EMA: 0.37 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 71.44 Sell
20-day SMA: 77.62 Sell
50-day SMA: 81.13 Sell
200-day SMA: 52.54 Buy
8-day EMA: 71.33 Sell
20-day EMA: 75.43 Sell
50-day EMA: 76.56 Sell
200-day EMA: 56.82 Buy

Prothena Corp. Plc Earnings Growth & PRTA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.32 per share, and an increase next year of $5.06 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Prothena Corp. Plc Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):